Johnson Gail V W, Stoothoff William H
Department of Psychiatry, University of Alabama at Birmingham, Birmingham, AL 35294-0017, USA.
J Cell Sci. 2004 Nov 15;117(Pt 24):5721-9. doi: 10.1242/jcs.01558.
Tau is a group of neuronal microtubule-associated proteins that are formed by alternative mRNA splicing and accumulate in neurofibrillary tangles in Alzheimer's disease (AD) brain. Tau plays a key role in regulating microtubule dynamics, axonal transport and neurite outgrowth, and all these functions of tau are modulated by site-specific phosphorylation. There is significant evidence that a disruption of normal phosphorylation events results in tau dysfunction in neurodegenerative diseases, such as AD, and is a contributing factor to the pathogenic processes. Indeed, the abnormal tau phosphorylation that occurs in neurodegenerative conditions not only results in a toxic loss of function (e.g. decreased microtubule binding) but probably also a toxic gain of function (e.g. increased tau-tau interactions). Although tau is phosphorylated in vitro by numerous protein kinases, how many of these actually phosphorylate tau in vivo is unclear. Identification of the protein kinases that phosphorylate tau in vivo in both physiological and pathological processes could provide potential therapeutic targets for the treatment of AD and other neurodegenerative diseases in which there is tau pathology.
Tau是一组神经元微管相关蛋白,由mRNA可变剪接形成,在阿尔茨海默病(AD)脑的神经原纤维缠结中积累。Tau在调节微管动力学、轴突运输和神经突生长中起关键作用,并且tau的所有这些功能都受到位点特异性磷酸化的调节。有大量证据表明,正常磷酸化事件的破坏会导致神经退行性疾病(如AD)中的tau功能障碍,并且是致病过程的一个促成因素。事实上,在神经退行性疾病中发生的异常tau磷酸化不仅会导致功能毒性丧失(如微管结合减少),还可能导致功能毒性增加(如tau-tau相互作用增加)。尽管tau在体外可被多种蛋白激酶磷酸化,但其中有多少在体内实际磷酸化tau尚不清楚。鉴定在生理和病理过程中在体内磷酸化tau的蛋白激酶可为治疗AD和其他存在tau病理的神经退行性疾病提供潜在的治疗靶点。